CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Poniard Pharmaceuticals, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Poniard Pharmaceuticals, Inc.
750 Battery St Ste 330
Phone: (206) 286-2501p:206 286-2501 SAN FRANCISCO, CA  94111  United States Ticker: PARDPARD

This company ceased filing statements with the SEC on 4/2/2012.

Business Summary
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201112/31/2010YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Ronald A.Martell 60 1/3/2012 6/26/2006
Independent Director Robert S.Basso 67 5/4/2007 5/4/2007
Independent Director Frederick B.Craves 77 5/1/2004 7/1/1993
3 additional Officers and Directors records available in full report.

Business Names
Business Name
NeoRx Corporation
PARD
Poniard Pharmaceuticals
Poniard Pharmaceuticals Inc.
Poniard Pharmaceuticals, Inc.

General Information
Number of Employees: 20 (As of 3/23/2011)
Outstanding Shares: 1,499,232 (As of 10/25/2011)
Shareholders: 564
Stock Exchange: OTC
Federal Tax Id: 911261311
Fax Number: (206) 284-2537


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023